Determining of Normal Values and Conformity Assessment of the Dosage of a Plasmatic Marker of the Cellular Captation of Glucose: the IRAP Protein

University Hospital, Grenoble96 enrolled

Overview

The purpose of this study is on one hand to verify the measurement conformity of the IRAP dosage and on the other hand to obtain normal values of the blood IRAP concentration on healthy volunteers.

This study consists of two visits, from two to five days apart. The first visit : * Healthy volunteers will be on an empty stomach. * they will have a clinical examination, blood tests and blood samples will be taken to constitute a blood collection. the IRAP concentration will be measured with those samples. The second visit : This visit will take place in an interval from 2 to 5 days after the first visit. * Subjects will be on an empty stomach * An oral glucose tolerance test (OGTT) of 3 hours will be performed. Blood samples will be taken three time 15 minutes apart at Baseline (before taking the glucose). And then after the glucose intake, blood sample will be taken every 15 minutes to measure insulinemia, blood glucose, and IRAP concentration.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Insulin Resistance

Interventions

Blood sample collection during an OGTT to assess IRAP blood concentrationOTHER

Blood sample collection during an OGTT to assess IRAP blood concentration. Blood samples will be collected every 15 minutes during 3 hours

Eligibility

Sex: ALLMin age: 40 YearsMax age: 70 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Body mass index between 19 and 25 Kg/m² * No intercurrent disease during the last week * No chronic infectious disease * No smoker, no alcoholic Exclusion Criteria: * history of : thyroid disease, liver or renal disease, endocrine and metabolic disease, cardiovascular disease, lung disease, gastroenterological disorders, psychiatric disease, Epilepsy * Consumption of narcotic drug * Blood donation dating less than 2 months * Pregnancy or breast-feeding, or intent to become pregnant during the study period * legal exclusion criteria

Locations (1)

Institut de Biologie - Pathologie

Grenoble, Isere, France

Outcomes

Primary Outcomes

Normal values of IRAP concentration will be calculated by making the average of the three dosages of IRAP measured at base line.

Three blood samples will be taken 15 minutes apart, before the OGTT. The average of IRAP concentration measured with those 3 samples, will be used to assess the normal values of IRAP concentration on a healthy population.

Time frame: At the beginning of the second visit of the study, before the glucose intake

Secondary Outcomes

Repeatability of the IRAP measurement

The repeatability will be assessed during the second visit. The measurement of IRAP concentration will be repeated 3 times on the first sample taken before the OGTT.

Time frame: At the beginning of the second visit of the study, before the glucose intake

Temporal reproducibility of the concentration of IRAP

The reproducibility will be assessed during the second visit. The measurement of IRAP concentration will be repeated 3 times on the first sample taken before the OGTT.

Time frame: At the beginning of the second visit of the study, before the glucose intake

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.